This retrospective observational study will assess the incidence of hemoglobin cycling in chronic kidney disease (stage 3, 4, and 5) patients with renal anemia treated with Mircera (methoxy polyethylene glycol-epoetin beta). Data will be collected from each patient from a 9-month treatment period.
Study Type
OBSERVATIONAL
Enrollment
1,288
Percentage of Participants With at Least One Hemoglobin Cycling
Hemoglobin cycling was defined as 1 or more cycles of oscillation in hemoglobin with an amplitude of greater than or equal to (\>=) 1.5 gram per deciliter (g/dL) and a duration \>=8 weeks.
Time frame: 9 months
Number of Full Hemoglobin Cycles Per Participant
Hemoglobin cycling was defined as 1 or more cycles of oscillation in hemoglobin with an amplitude of \>=1.5 g/dL and a duration \>=8 weeks.
Time frame: 9 months
Percentage of Participants With Type 2 Diabetes Who Experienced at Least 1 Hemoglobin Cycling
Hemoglobin cycling was defined as 1 or more cycles of oscillation in hemoglobin with an amplitude of \>=1.5 g/dL and a duration \>=8 weeks.
Time frame: 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Timios Stavros Clinic; Nephrology Department
Aigáleo, Greece
General Hospital of Artas; Nephrology
Arta, Greece
Attikon Center; Nephrology
Athens, Greece
Athinaiki Private Clinic
Athens, Greece
Hospital henry dunant; Nephrology
Athens, Greece
General Hospital Hippokration of Athens; Nephrology
Athens, Greece
General Hospital Of Athens G.Gennimatas; Nephrology
Athens, Greece
Kyanos Stavros Private Hospital; Nephrologic Clinic
Athens, Greece
General Hospital Of West Attikis; Nephrology
Athens, Greece
University Hospital Attikon ; Pathology Clinic
Athens, Greece
...and 23 more locations